Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. 1993

S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
Institute of Pharmacological Sciences, University of Milan, Italy.

We attempted to determine whether changes in protein kinase C (PKC) activity in Alzheimer's disease (AD) brains are also present in cultured skin fibroblasts from living patients. Biopsies collected from shoulder skin were transferred to culture plates with an appropriate growth medium, and histone-directed PKC activity as well as phorbol ester binding were individually determined in soluble and particulate fractions prepared from AD and non-AD fibroblast cell lines. Binding experiments indicated that PKC was unevenly distributed between cytosol (78%) and particulate (22%). The Bmax values for phorbol ester binding in soluble and particulate fractions were similar in AD and non-AD patients. Kd values in the cytosol were 94% higher in AD patients, indicating lower affinity of the enzyme for the ligand. Accordingly, the soluble PKC activity was 30% lower in AD patients. The data suggest that the changes in PKC phosphorylating activity represent a diffuse cellular defect in AD and are not confined to the brain. The alterations of the enzyme may participate in the disregulation in processing of beta-amyloid precursor protein in AD.

UI MeSH Term Description Entries
D008297 Male Males
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
November 1991, Neuroscience letters,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
November 1989, Archives of neurology,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
March 1999, Biochimica et biophysica acta,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
November 1992, Nature,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
September 1996, Molecular carcinogenesis,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
January 1990, Advances in experimental medicine and biology,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
January 1994, Neurobiology of aging,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
March 1998, The Biochemical journal,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
December 2008, Neurochemical research,
S Govoni, and S Bergamaschi, and M Racchi, and F Battaini, and G Binetti, and A Bianchetti, and M Trabucchi
August 1997, Brain research,
Copied contents to your clipboard!